Post-marketing surveillance study of the safety of dexamethasone intravitreal implant in patients with retinal vein occlusion or noninfectious posterior segment uveitis

Código QR

Post-marketing surveillance study of the safety of dexamethasone intravitreal implant in patients with retinal vein occlusion or noninfectious posterior segment uveitis

Adnan Tufail,1 Sue Lightman,1 Ahmed Kamal,2 Uwe Pleyer,3 Nuria María Gajate Paniagua,4 Corrine Dot,5,6 Xiao-Yan Li,7 Jenny Jiao,7 Jean Lou,7 Yehia Hashad7 For the CONSTANCE Study Group 1Moorfields Eye Hospital, London, UK; 2Aintree University Hospital, Liverpool, UK; 3Un...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Tufail A, Lightman S, Kamal A, Pleyer U, Gajate Paniagua NM, Dot C, Li XY, Jiao J, Lou J, Hashad Y
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	corticosteroid dexamethasone drug delivery device retinal vein occlusion safety profile uveitis Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/49c25c24a1c04ef4b9126cabaafb125b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Initial Ten Years of Experience with the Intravitreal Dexamethasone Implant: A Retrospective Chart Review
por: Wallsh J, et al.
Publicado: (2020)

Dexamethasone implant in retinal vein occlusions
por: Han SB, et al.
Publicado: (2016)

Long-term results of combination therapy using anti-VEGF agents and dexamethasone intravitreal implant for retinal vein occlusion: an investigational case series
por: Singer MA, et al.
Publicado: (2016)

Usefulness of anti-vascular endothelial growth factor combined with dexamethasone implant for retinal vein occlusion
por: Kim M
Publicado: (2016)

Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naïve retinal vein occlusion related macular edema
por: Laine I, et al.
Publicado: (2017)

Therapeutic effect of dexamethasone implant in retinal vein occlusions resistant to anti-VEGF therapy
por: Wallsh J, et al.
Publicado: (2016)

Management of noninfectious posterior uveitis with intravitreal drug therapy
por: Tan HY, et al.
Publicado: (2016)

Dexamethasone Intravitreal Implant for the Treatment of Macular Edema Following Retinal Vein Occlusion: Post Hoc Analysis of Post-Marketing Surveillance Data in the Real-World Setting in Korea
por: Kim MS, et al.
Publicado: (2021)

Evaluation of the effectiveness and safety of glucocorticoids intravitreal implant therapy in macular edema due to retinal vein occlusion
por: Michalska-Małecka K, et al.
Publicado: (2016)

Effects of Repeated Intravitreal Injections of Dexamethasone Implants on Intraocular Pressure: A 4-Year Study
por: Pacella E, et al.
Publicado: (2020)

Treatment of refractory uveitic macular edema: results of a first and second implant of long-acting intravitreal dexamethasone
por: Zola M, et al.
Publicado: (2017)

Dexamethasone intravitreal implant for the treatment of noninfectious uveitis
por: Hunter RS, et al.
Publicado: (2011)

Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant
por: Jane S Myung, et al.
Publicado: (2010)

Outcomes of treatment with sirolimus for non-infectious uveitis: a meta-analysis and systematic review
por: Cabahug VLO, et al.
Publicado: (2019)

Effect of intravitreal ranibizumab on serous retinal detachment in branch retinal vein occlusion
por: Dogan E, et al.
Publicado: (2018)

Biological Therapy in Noninfectious Pediatric Uveitis: A Systematic Review
por: Norcia LF, et al.
Publicado: (2021)

A review and update on orphan drugs for the treatment of noninfectious uveitis
por: You C, et al.
Publicado: (2017)

Intravitreal ziv-aflibercept for macular edema following retinal vein occlusion
por: Paulose R, et al.
Publicado: (2016)

Short-term outcomes in patients with branch retinal vein occlusion who received intravitreal aflibercept with or without intravitreal ranibizumab
por: Sakanishi Y, et al.
Publicado: (2017)

The outcome of low-frequency intravitreal bevacizumab therapy for macular edema in retinal vein occlusions
por: Ivanovska Adjievska B, et al.
Publicado: (2017)

Characteristics of Somatic Status and Individual Biochemical Markers in Patients with Retinal Vein Occlusion
por: I. V. Zlobin, et al.
Publicado: (2019)

Central retinal vein occlusion and pseudoexfoliation syndrome
por: Karagiannis D, et al.
Publicado: (2015)

Twelve-month outcomes in patients with retinal vein occlusion treated with low-frequency intravitreal ranibizumab
por: Sakanishi Y, et al.
Publicado: (2016)

Clinical therapeutic effects of intravitreal injection of Conbercept for macular edema in different types of retinal vein occlusion
por: Peng-Yao Lin, et al.
Publicado: (2021)

Macular edema associated with non-infectious uveitis: pathophysiology, etiology, prevalence, impact and management challenges
por: Massa H, et al.
Publicado: (2019)

Multicenter, Prospective, Randomized Study of Dexamethasone Intravitreal Implant in Patients with Center-Involved Diabetic Macular Edema in the Asia-Pacific Region
por: Wei W, et al.
Publicado: (2021)

Anti-VEGF treatment of macular edema associated with retinal vein occlusion: patterns of use and effectiveness in clinical practice (ECHO study report 2)
por: Jumper JM, et al.
Publicado: (2018)

Retinal vascular occlusion: a window to diagnosis of familial and acquired thrombophilia and hypofibrinolysis, with important ramifications for pregnancy outcomes
por: Dixon SG, et al.
Publicado: (2016)

Comprehensive Treatment of Noninfectious Uveitis Accompanied by Macular Edema with the Use of Autologous Platelet-Rich Plasma
por: N. S. Arbenyeva, et al.
Publicado: (2019)

VISUAL OUTCOME AFTER INTRAVITREAL BEVACIZUMAB (AVASTIN) IN THE TREATMENT OF BRANCH RETINAL VEIN OCCLUSION
por: Saquib Naeem, et al.
Publicado: (2019)

Six-month results of intravitreal ranibizumab for macular edema after branch retinal vein occlusion in a single-center prospective study: visual outcomes and microaneurysm formation
por: Kawamura M, et al.
Publicado: (2018)

Efficacy and tolerability of bilateral sustained-release dexamethasone intravitreal implants for the treatment of noninfectious posterior uveitis and macular edema secondary to retinal vein occlusion
por: Ryder SJ, et al.
Publicado: (2015)

Retinal vein occlusion with cerebral infarction in a preterm neonate: a case report
por: Xiuyu Zhu, et al.
Publicado: (2021)

Long-term outcomes of intravitreous bevacizumab or tissue plasminogen activator or vitrectomy for macular edema due to branch retinal vein occlusion
por: Kumagai K, et al.
Publicado: (2019)

Comparison between intravitreal bevacizumab and posterior sub-tenon injection of triamcinolone acetonide in macular edema secondary to retinal vein occlusion
por: Tsai MJ, et al.
Publicado: (2018)

Effectiveness of 190 μg Fluocinolone Acetonide and 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis
por: Zarranz-Ventura J, et al.
Publicado: (2020)

TRANSPUPILLARY THERMOTHERAPY OF THE OPTIC NERVE DISK IN THE TREATMENT OF CENTRAL RETINAL VEIN OCCLUSION
por: M. V. Akulenko, et al.
Publicado: (2016)

Síndrome nefritis intersticial aguda y uveitis
por: García de Cortazar G,Laura, et al.
Publicado: (1991)

Systemic abnormalities associated with retinal vein occlusion in young patients
por: Sinawat S, et al.
Publicado: (2017)

Granulomatous Features in Juvenile Idiopathic Arthritis-Associated Uveitis is Not a Rare Occurrence
por: Papasavvas I, et al.
Publicado: (2021)